Introduction
The feasibility of identifying cell surface receptors or molecules in vivo is limited by the myriad molecular sites available in complex tissues or organs. Screening of lungspecific ligands has extensive application especially for targeting gene delivery. Targeting to the specific lung cells is limited by the diversity of cell types in the lung. 1 Efficacy of targeted therapy is further hampered by the fact that lung epithelial cells and macrophages are relatively refractory to current vectors used for gene therapy compared with other cell types. [2] [3] [4] For example, adenoviral vectors are not very effective when transfecting lung epithelial cells owing to the low level of the Coxsackieadenovirus receptor, required for efficient virus-cell interaction. 5 If there were available methods to enhance receptor or cell surface molecule identification, the efficiency for tissue-target cell interaction could be increased.
Alveolar epithelial cells are a potentially attractive target for possible therapeutic intervention in a number of pulmonary disorders including pulmonary fibrosis, pulmonary infections, and the acute respiratory distress syndrome. 3, 4, [6] [7] [8] [9] The proximity of these cells to both the bloodstream and gas-exchange units enhances their attractiveness as potential targets in molecular therapy of various lung disorders.
Previous studies have demonstrated that molecular delivery of phage libraries can be targeted to individual cell types in vitro, thus generating cell-specific therapeutic vehicles. [10] [11] [12] However, selection of a target in the lung is limited by the large surface area and the variety of cell types. Phage display has been applied to search for specific molecular ligands/ligates. 13 This powerful technique permits millions of variants to be screened quickly and efficiently for their capacity to interact with diverse cell populations with organ systems even though the compositions of the target structure are largely unknown. Recently, Pasqualini and co-workers 14, 15 have used bloodborne delivery of phage peptide libraries for in vivo selection of lung and other organ endothelium-specific peptides. The isolation of novel peptides that mediate selective attachment and internalization of biological vehicles into alveolar epithelial cells has not been reported.
We report the successful selection and identification of peptides that attach and bind selectively to lung epithelial cells. Furthermore, using a variety of methods we demonstrate that the selected peptides target binding sites of alveolar lining cells.
Methods

Phage libraries
The fUSE5/15 mer, F88-4/15 mer, and F88-4/Cys1/13-mer phage display peptide libraries display random linear 13-15-mer peptides and were gifts from Dr G Smith of the University of Missouri. 10 The F88-4/Cys1/ 13-m23 library was a constrained library containing two cysteines within its sequence. 16 The chemical diversity of the libraries is estimated to be 2 Â 10 8 for fUSE5 and 5.5 Â 10 7 for F88-4/Cys1. 20 After 30 min, the mice were killed and the lungs were lavaged with Hanks' solution for a total volume of 10 ml. The lungs were homogenized, and the supernatants were centrifuged. The supernatants were then used to infect E. coli ER2537 (New England Biolab, Beverly, MA, USA). TU were determined by enumerating colonies of phageinfected E. coli using the fUSE5/15 phage library from lung homogenates. The phages obtained from each mouse were then reintroduced intratracheally into another mouse for five subsequent rounds. The expanded phage libraries were purified using Na/PEG precipitation 10 and then another round of selection began by instilling the library into the lung of another mouse. Phage libraries were amplified, purified, and titered as described by Smith and co-workers. 10, 16 For further binding studies, high-titer homogeneous populations of each phage were prepared and identified using DNA sequencing.
Assessment of the phage clones binding to the lung cells in vitro and in vivo
Each selected phage (1 Â 10 10 PFU) was intratracheally instilled into the lung while the mouse received mechanical ventilation as previously described. 20 After 30 min, unbound phages were removed by bronchoalveolar lavage (BAL) 8 and the resultant lung-associated phages were titered and detected using anti-M13 Mab histochemistry. The percent recovery was calculated for each cell type using a peptideless phage to quantify background binding. After reacting with phage clones, lungs were perfused using lavage solution containing 10 U/ml heparin. For paraffin sections, lungs were excised en bloc after fixation with 10% buffered formalin phosphate (Fisher Scientific, Fair Lawn, NJ, USA). For cryosections, lungs were perfused and inflated with 1 ml of 50% Tissue-Tek OCT compound (Sakura Finetek USA Inc., Torrance, CA, USA) and then excised en bloc. The sections were reacted with a 1:300 dilution of anti-M13 phage antibodies (Pharmacia, Piscataway, NJ, USA) and then stained with HistoMark Red (KPL, Gaithersburg, MD, USA).
We also performed in vitro cell-binding assays using several cell types. To quantify binding of a selected phage, cells were plated into six-well plates and then 1 Â 10 7 TU of phage clone was used to pan cells including A549, lung epithelial type II cells, and Hep2 at 41C for 30 min. Unbound phages were removed by stringent washing, and the resultant cell-associated phages were titered and counted using ELISA.
Assessment of synthetic peptide binding in vitro and in vivo
Selected affinity peptides and random control peptides (the same compositions) were synthesized by Genmed Synthesis Inc. (South San Francisco, CA, USA). The binding sites in the lung were confirmed using FITClabeled synthetic peptides. 21 Specificity of binding was examined by competition using nonlabeled peptide (0.1-100 mM) or control peptide (0.1-100 mM).
Peptide binding to cells detected by ELISA
Detection of peptide binding to 10 5 monolayer cells (A549 or Hep2) was performed using cell ELISA as previously described. 22 
Western blotting
This was carried out as described previously.
Statistical analysis
Data were analyzed by unpaired Student's t-test or oneway ANOVA and were shown as mean7s.d. Data were considered significant when Po0.05.
Results
Phage display identifies peptides binding to the lung
We used multiple strategies to isolate alveolar-targeting phages in vivo. First, we used mechanical ventilation to ensure broad alveolar deposition of the targeting phages, as previously described from our laboratory. 8, 20 Second, we instilled the fUSE5/15-mer linear phage library and completed five rounds of selection to identify peptide sequences. To verify that we were selectively enriching the library for epithelium-targeting phages, we titered phages after each round of selection. A significant increase in the titer of phages was observed. After five rounds, we isolated and identified 51 individual phages. A total of 58 different peptide sequences were identified. Frequency (repeated appearance of one sequence) was used as an indicator of enrichment. One of the peptides (designated LEBP-2, RNVPPIFNDVYWIAF) appeared repeatedly in 16 out of 20 randomly picked clones (80% frequency). A number of motifs were identified. For example, XGFX, XGXF, XSR and XSAX, particularly XGFX, appeared more than 14 times. Also, XSR motifs appeared at the N-terminus.
Third, we modified the selection protocol using phage library F88-4/15 mer and constraint library F88-4/Cys1/ 13 mer for screening peptides. Use of the constraint library facilitated the selection of high-affinity binding peptides. 23, 24 In addition, we sonicated the lung for 3 Â 15 s using a dismembrator and eluting the phages from the lung using pH 2.2 0.1 M HCl, which significantly enhanced the recovery of specifically enriched binding phages. A total of 28 additional individual phages were identified. With this strategy after five rounds of selection, a number of different peptides were isolated that appeared in high frequency. A peptide designated LEBP-1 (QPFMQCLCLIYDASC) appeared 24 times out of randomly picked 32 clones (75% frequency). LEBP-3 (VFRVRPWYQSTSQS) was also identified as a specific peptide binding to lung cells. Furthermore, a series of new motifs were found with a frequency of 69% including CSC.
The selected phage clones were enriched after five rounds of selection. Results demonstrated that the enrichment from starting materials to the final round of selected populations ranged from 10-to 32-fold ( Figure 1 ). Affinity binding is reflected by increased recovery of TU after five rounds of selections. Through the selections, all the phages derived from the four groups revealed increased binding to the lung, while the phages derived from mouse group one had the highest TU and this correlated with the highest binding affinity to the lung. Following the modification of the selection protocol, the enrichment was further increased to 40-fold. This suggests that the selection process was a successful enrichment for peptides that may have specific binding to alveolar epithelial cells.
In vitro binding to the lung using selected phage clones
Phage clones were expanded and isolated to obtain homogeneous phages at 10 12 PFU. The clones were incubated with BALB/c mouse lung cryosections. Using anti-M13 monoclonal antibodies, selected phage clones expressing specific peptides bound to the lung tissue, while the control phages from the starting library did not specifically bind to the lung (Figure 2 ). The selected phage clones did not bind to other organs (spleen, heart, brain, liver, and intestine). Finally, the selected phage clone staining accumulated in and around type II epithelial cells, suggesting that selected phage might bind to type II epithelial cells. This was further confirmed by colocalization of type II cells with surfactant protein antibodies (Figure 2e, f) , suggesting that the binding site for the selected peptides on the lung cells apparently overlaps with the binding site of the SP-C antibody.
In vivo binding to the lung using selected phage clones Phage-directed binding was also assessed in vivo using the selected and purified phage clones using anti-M13 antibodies. Binding of phage clones to the lung was confirmed in both cryosections (Figure 3a ) and paraffinembedded sections (Figure 3b ) of the lung. In contrast, the control phages were not bound to the lung. In addition, phage clones were biotinylated before intratracheal administration, the lungs were sectioned, and the phages were detected via biotin-avidin binding using a HistoMark kit.
Synthesized peptides binding to the lung
Selected peptides, particularly lung epithelial binding peptide 1 (LEBP-1) and LEBP-2, showed strong selective binding to the lung (Figure 4a, b) , while the control peptide did not bind (Figure 4c ). The binding pattern appeared to involve all alveolar surfaces rather than directed alveolar cell populations. However, the staining of cells was stronger in the corners of alveoli, a location typical of type II alveolar cells. This was further confirmed when the peptide was intratracheally instilled into the lung of BALB/c mice. Again, the selected peptide showed strong binding to lung cells in vivo, while the control peptide did not bind (data not shown).
In vitro binding to lung cell lines using selected peptides
After selection of putative epithelium-specific peptides, pure high-titer stocks of homogeneous phages were generated to further analyze their binding to A549, type II, and Hep2 cells. Recovery of attached phages from Hep2 was 2.970.5% as compared to recovery from A549 cells of 35.472.3%. All three peptides tested revealed significantly more binding to A549 cells than Hep2 cells. Synthesized peptides were labeled with FITC. LEBP-1 had specific binding to A549 cells (Figure 5a ) or type II cells (Figure 5b ), but had no binding to Hep2 cells Figure 1 TU were determined by enumerating colonies of phage-infected E. coli using the fUSE5/15 phage library from lung homogenates. The phages obtained from each mouse were then reintroduced intratracheally into another mouse for five subsequent rounds. Following five rounds of affinity selection and enrichment, all the phages derived from four groups show enhanced affinity to the lung. However, the phage derived from mouse group one correlated with highest binding affinity to the lung. This result demonstrates that in vivo phage display in the lung facilitated the selection of lung-specific binding peptides. 
Detection of phage clones in lung cells using immunogold transmission electron microscopy
We tested if the binding of phage clones to the lung cells could be monitored using immunogold labeling of phage Mapping lung-binding sites in vivo M Wu et al in cultured A549 cells. As expected, the gold particles following the binding of LEBP-1 phage were found on the cell membrane of A549 cells as well as in the cytoplasm. In contrast, the peptideless phage control did not appear in the cells (Figure 7 ). The affinity binding was statistically analyzed by counting cells with gold particles resulting from the phage-specific binding,
suggesting that the cells with gold particles were because of the addition of the affinity-selected phages.
Discussion
We used random phage display libraries expressing 15-mer peptides on their coat proteins to probe epithelial Phage display has been used to screen small peptides for studying protein-peptide interactions as well as for therapeutic intervention. We tried various phage libraries and used a couple of strategies to select higher affinity peptides that bind the alveolar cell surface. The modified protocol of selection enriched candidate peptides, because the phage containing peptide LEBP-1 appeared to bind to lung cells more efficiently than the earlier phage selection strategy. Further, the peptide selected with the second method appeared during the second, third and fourth rounds, although all the selections continued till the fifth round. The success of the technique was highlighted when high-titer stocks of pure populations of these peptide-expressing phages were used in repeated selection and enrichment experiments in vivo. Here, all three peptides tested showed significantly higher recovery from alveolar epithelial cells than from other cell types such as Hep2. This is similar to the results of Pasqualini and Ruoslahti, 14 Rajotte et al, 15 and Altschul et al, 25 who recovered fourfold more phages that expressed the peptide CGFECVRQCPERC from cells positive for the target receptor, membrane dipeptidase, than the recovery for control phage without an insert. Previously, a GFE motif was confirmed to be associated with lung epithelial binding affinity. 15 Unfortunately, although we have found a number of motifs that appeared in the peptides after several round selections, we failed to identify one motif that exists in all the peptides.
We have increased the selecting time to 30 min or 1 h as compared with the report of Pasqualini and coworkers, 14, 15 who used 4 min binding in selection of endothelial-specific peptides. Samoylova and Smith 26 used 15 min incubations for selecting muscle-binding peptides. Our results indicate that peptides with stronger binding affinity can be selected by incubating for a longer time during selection. Perhaps the route of administration, for example, intratracheal versus intravenous, could account for the different optimal times for binding.
Studies on freshly isolated alveolar epithelial type II cells and monolayer A549 lung epithelial cells revealed that selected phage clones or peptides have particular affinity to the lung cells compared to nonlung cells. The selected phage clones and FITC-labeled synthesized peptides bind alveolar lining cells in vivo, suggesting that the phages or peptides recognize surface molecules within the alveolar spaces.
It is possible to identify cell surface receptors for peptides and to study the biological function of the receptors. 27 The use of phage libraries to identify unique peptides may be of fundamental value in resolving the molecular architecture of the alveolar epithelial surface and in the development of new approaches to study the roles of alveolar epithelial cells during injury and repair. By testing for homology for our newly identified peptides using BLAST, LEBP-3 was found to be closely homologous to the interferon regulatory factor 7 (IRF-7), indicating that the peptide may bind the receptor of IRF-7 on alveolar epithelial cells. Therefore, this peptide may be useful for inducing type I interferon.
Use of phage display to map organ systems is still in its infancy. As an example, in vivo phage display has been used to home phages to a variety of organs for specific vascular addresses. 28 Arap et al 29 have reported the first phage display in a patient screening 47,160 molecular motifs localized to different organs. These data may represent a step toward the construction of a molecular map of the human vasculature and may have broad implications for the development of targeted therapies. We have shown the possible use of intratracheal delivery of phage libraries for exploring the molecular diversity of the airway epithelium in the lower respiratory tract.
In our model, we observed enhanced binding to alveolar epithelial cells using the selected peptides. The use of specific peptides might improve the safety profile and target efficiency in gene transfer to alveolar epithelial cells. Recently, Trepel et al 30 have used a peptide selected via in vivo phage display to target adenoviral gene delivery. Our study suggests that the use of lung-binding peptides may be useful for in vivo gene targeting alveolar epithelial surface.
In summary, novel peptides isolated from random phage display libraries may efficiently bind to alveolar epithelial cells, such as A549 or type II epithelial cells. Our study highlights the potential applications of small peptides in molecular therapy protocols in which in vivo selective transduction of epithelial cells would be advantageous. High-affinity tissue-specific peptides may have a broad range of usage including study of cell ligand-receptor binding, diagnostic analysis, and therapeutic regulation of biological functions. Finally, our selection approach of in vivo airway delivery of phage library would be applicable in other molecular ligands including antibody fragments that may be useful for gene targeting.
